UPMC Hillman Cancer Center

Meeting Schedule

Hillman PRC/PRMS committee meeting dates and deadlines for submission for 2018 are as follows:

COMMITTEE A
3:30-5:00pm, 5 East Conference Room
Andrew Laman, MD (Chairman)

COMMITTEE B
2:00-3:30pm, 5 East Conference Room
Leonard Appleman, MD (Chairman)

Deadline Dates For Submission Meeting Dates Deadline Dates For Submission Meeting Dates
December 20, 2017 January 8, 2018 January 8, 2018 January 22, 2018
January 22, 2018 February 5, 2018 February 5, 2018 February 19, 2018
February 19, 2018 March 5, 2018 March 5, 2018 March 19, 2018
March 23, 2018 April 9, 2018 April 9, 2018 April 23, 2018
April 23, 2018 May 7, 2018 May 7, 2018 May 21, 2018
May 23, 2018 June 11, 2018 June 11, 2018 June 25, 2018
June 25, 2018 July 9, 2018 July 9, 2018 July 23, 2018
July 23, 2018 August 6, 2018 August 6, 2018 August 20, 2018
August 22, 2018 September 10, 2018 September 10, 2018 September 24, 2018
September 24, 2018 October 8, 2018 October 8, 2018 October 22, 2018
October 22, 2018 November 5, 2018 November 5, 2018 November 19, 2018
November 19, 2018 December 3, 2018 December 3, 2018 December 17, 2018

Deadlines for submission to the PRC/PRMS are approximately 2 weeks before the scheduled meeting date. Please note that any trials lacking the required documentation for review by EOB on the dates listed above may not be guaranteed on the next meeting agenda.

Required documents include the following:

  1. A completed PRC/PRMS checklist/program director letter
  2. A copy of full protocol (unsecured)
  3. A sponsor and/or Hillman consent form
  4. Investigator drug brochure
  5. All trials must receive sign-off from the Disease Center Director and all investigator-initiated trials must be approved by a University of Pittsburgh Biostatistician prior to submission to the PRC/PRMS (signature on checklist).

Finalized documents can be emailed to Brandon Kaukus at kaukusbm@upmc.edu or call 412-623-3376 if you have any questions.

Note: Any studies with Chairman as PI should be sent to the opposite committee for review.